Literature DB >> 33000631

A novel decatenation assay for DNA topoisomerases using a singly-linked catenated substrate.

Nidda F Waraich1, Shruti Jain2,3, Sean D Colloms4, William Marshall Stark4, Nicolas P Burton2, Anthony Maxwell1.   

Abstract

Decatenation is a crucial in vivo reaction of DNA topoisomerases in DNA replication and is frequently used in in vitro drug screening. Usually this reaction is monitored using kinetoplast DNA as a substrate, although this assay has several limitations. Here we have engineered a substrate for Tn3 resolvase that generates a singly-linked catenane that can readily be purified from the DNA substrate after restriction enzyme digestion and centrifugation. We show that this catenated substrate can be used with high sensitivity in topoisomerase assays and drug-inhibition assays.

Entities:  

Keywords:  antibiotics; anticancer drugs; decatenation; gyrase; topoisomerase

Year:  2020        PMID: 33000631     DOI: 10.2144/btn-2020-0059

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  3 in total

1.  Topoisomerase VI is a chirally-selective, preferential DNA decatenase.

Authors:  Shannon J McKie; Parth Rakesh Desai; Yeonee Seol; Adam Mb Allen; Anthony Maxwell; Keir C Neuman
Journal:  Elife       Date:  2022-01-25       Impact factor: 8.140

2.  Topoisomerase Assays.

Authors:  John L Nitiss; Kostantin Kiianitsa; Yilun Sun; Karin C Nitiss; Nancy Maizels
Journal:  Curr Protoc       Date:  2021-10

Review 3.  Processing DNA lesions during mitosis to prevent genomic instability.

Authors:  Anastasia Audrey; Lauren de Haan; Marcel A T M van Vugt; H Rudolf de Boer
Journal:  Biochem Soc Trans       Date:  2022-08-31       Impact factor: 4.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.